MSB 5.33% $1.07 mesoblast limited

2023 The Final Countdown, page-64

  1. 581 Posts.
    lightbulb Created with Sketch. 279
    @dachopper great post , I don't know how i missed it till now... I have been searching for evidence of recent early FDA approvals... and here it is on HC

    Thank you great Sluething mate...


    from dachopper post on the 9th March...

    GVHD approval decision 2 Apr 23 to 2 Aug 23 ( 2 - 6 months for fast track*)

    *Zanubrutinib - a drug for treating mantle cell lymphoma, was approved over 3 months ahead of its PDUFA date, late in 2019, along with at least onother 4 drugs, all approved earlier than the PDUFA date given by the FDA.
    Crizanlizumab-tmca approved 2 months before PDUFA in 2020.
    Voxelotor accelerated approval three months before PDUFA.
    Givosiran 2.5 months before it's PDUFA date.
    It is not a given that the yes / no will occur on the actual PDUFA date.
    Source : https://endpts.com/fda-approves-5-new-costly-drugs-well-ahead-of-pdufa-dates/

    very pleasing to see above...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.060(5.33%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.14 $1.14 $1.07 $5.556M 5.065M

Buyers (Bids)

No. Vol. Price($)
12 193123 $1.06
 

Sellers (Offers)

Price($) Vol. No.
$1.07 300057 2
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
$1.07
  Change
-0.060 ( 5.22 %)
Open High Low Volume
$1.13 $1.14 $1.07 1328053
Last updated 15.59pm 05/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.